Tag archive for ‘Cardiovascular disease’
By pharmanewsdaily On Sunday, June 14th, 2020

Novo Nordisk to acquire cardio-renal disease company Corvidia Therapeutics

Novo Nordisk acquisition of Corvidia : Danish pharma company Novo Nordisk has agreed to acquire Corvidia Therapeutics from life sciences venture capital firm Sofinnova Partners in a deal worth up to $2.1 billion, More...

By pharmanewsdaily On Saturday, February 22nd, 2020

Lilly bags Trulicity FDA approval for reducing CV risk in type 2 diabetes patients

Trulicity FDA approval : Eli Lilly and Company (Lilly) has secured approval from the US Food and Drug Administration (FDA) for Trulicity (dulaglutide) to reduce major cardiovascular events (MACE) in type 2 diabetes More...

By pharmanewsdaily On Monday, December 16th, 2019

Amarin bags Vascepa FDA approval for reducing cardiovascular risk

Vascepa FDA approval : New Jersey-based Amarin has secured approval from the US Food and Drug Administration (FDA) for a new indication and label expansion for Vascepa (icosapent ethyl) capsules. The FDA has now More...

By pharmanewsdaily On Monday, November 25th, 2019

Novartis to acquire The Medicines Company for $9.7bn with eye on inclisiran

Novartis acquisition of The Medicines Company : Swiss drugmaker Novartis signed a deal worth $9.7 billion to acquire US biopharma company The Medicines Company, as per the latest pharma acquisition news. As per More...

By pharmanewsdaily On Monday, January 28th, 2019

An egg a day might reduce risk of heart disease: Study

New Delhi, Jan 28 (ANI): A new study conducted in China finds that eating an egg a day may lower risk of cardiovascular disease. The study found that daily egg eaters had an 18 per cent lower risk of dying from More...

By pharmanewsdaily On Tuesday, September 17th, 2013

What meant is by Tachycardia?

Tachycardia: Tachycardia is a medical term for the conditions like rapid heart beat, fluttering heart or pounding of heart. Causes for Tachycardia: Sinus tachycardia (Photo credit: Wikipedia) This condition occurs More...